Concorde Asset Management, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Concorde Asset Management, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$3,223,000
+154.8%
73,982
+157.8%
2.14%
+183.6%
Q4 2021$1,265,000
+29.3%
28,693
+12.1%
0.76%
+33.9%
Q3 2021$978,000
-69.2%
25,598
-67.9%
0.56%
-68.4%
Q2 2021$3,176,000
+96.4%
79,765
+76.1%
1.78%
+91.3%
Q1 2021$1,617,00045,3020.93%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders